Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Shah I, Chiang S, Yang L, Akeno N, Kelly A, White J, Caywood E, Hwang S, Le T. ?d CD8+ T cells and novel genetic variants in ZAP70 deficiency. Pediatr Allergy Immunol. 2023 10; 34(10):e14035.
-
Seyedin R, Snider JT, Rajagopalan K, Wade SW, Gergis U. Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma. Future Oncol. 2023 Jul; 19(22):1535-1547.
-
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. ?-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023 Jul; 24(7):811-822.
-
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A. Targets and cross-reactivity of human T?cell recognition of common cold coronaviruses. Cell Rep Med. 2023 06 20; 4(6):101088.
-
Domeier PP, Rahman ZSM, Ziegler SF. B cell- and T cell-intrinsic regulation of germinal centers by thymic stromal lymphopoietin signaling. Sci Immunol. 2023 01 06; 8(79):eadd9413.
-
Contreras AV, Wiest DL. Development of ?d T Cells: Soldiers on the Front Lines of Immune Battles. Methods Mol Biol. 2023; 2580:71-88.
-
Sertori R, Zhang Y, Wiest DL. Zebrafish: A Tractable Model for Analysis of T Cell Development. Methods Mol Biol. 2023; 2580:355-377.
-
Gleason L, Nikbakht N. Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides. JAMA Dermatol. 2023 Jan 01; 159(1):116.
-
Tilsed CM, Principe N, Kidman J, Chin WL, Orozco Morales ML, Zemek RM, Chee J, Islam R, Fear VS, Forbes C, Aston WJ, Jansen M, Chopra A, Lassmann T, Nowak AK, Fisher SA, Lake RA, Lesterhuis WJ. CD4+ T?cells drive an inflammatory, TNF-a/IFN-rich tumor microenvironment responsive to chemotherapy. Cell Rep. 2022 12 27; 41(13):111874.
-
Yi D, Gergis M, Hsu J, Yang Y, Bi X, Aljurf M, Gergis U. Next-Generation Chimeric Antigen Receptor T-cells. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):117-121.